Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
131 participants
INTERVENTIONAL
2015-01-31
2015-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Tolerance of Healthy Infants Fed Infant Formulas
NCT02401217
Gastrointestinal Tolerance Evaluation of an Infant Formula
NCT03307122
Tolerance of Healthy, Term Infants to Infant Formulas
NCT00543673
Formula Tolerance of Term Infants
NCT04915937
Behavior of Infants Fed Formula Supplemented With Prebiotics
NCT02757924
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Experimental 1 Infant Formula
Milk-based infant formula without prebiotics
Experimental 1 Infant Formula
Ready to feed infant formula to be fed ad-libitum
Experimental 2 Infant Formula
Milk-based infant formula with prebiotics
Experimental 2 Infant Formula
Ready to feed infant formula to be fed ad-libitum
Human Milk-Fed Reference Group
Breast fed infants
Reference Group
Breast fed ad libitum
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Experimental 1 Infant Formula
Ready to feed infant formula to be fed ad-libitum
Experimental 2 Infant Formula
Ready to feed infant formula to be fed ad-libitum
Reference Group
Breast fed ad libitum
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Infant is a singleton from a full term birth with a gestational age of 37-42 weeks.
* Infant's birth weight was \> 2490 g (\~5 lbs 8 oz.).
* Infant is between 0 and 8 days of age at enrollment.
* Parent(s) confirm their intention to feed their infant the study product (formula-fed infants) or human milk (human milk-fed infants) as the sole source of nutrition for the duration of the study.
* Parent(s) confirm their intention not to administer vitamin or mineral supplements, solid foods or juices to their infant from enrollment through the duration of the study.
Exclusion Criteria
* Infants using medications, home remedies, herbal preparations, probiotics or rehydration fluids that might affect GI tolerance.
* Mother intends to use a combination of breast and formula feeding.
* Participation in another study that has not been approved as a concomitant study by AN.
8 Days
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Abbott Nutrition
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Janice Kajzer, MS, RD, LD
Role: STUDY_CHAIR
Abbott Nutrition
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
W.O.M.B Watching Over Mothers and Babies
Tucson, Arizona, United States
Clinical Research Advantage/Colorado Springs Health Partners
Colorado Springs, Colorado, United States
Norwich Pediatric Group, PC
Norwich, Connecticut, United States
SCORE Physician Alliance, LLC
St. Petersburg, Florida, United States
Michael W. Simon, M.D., PSC
Nicholasville, Kentucky, United States
Women's Clinic of Lincoln, PC.
Lincoln, Nebraska, United States
White Oak Family Physicians DBA Asheboro Research Associates
Asheboro, North Carolina, United States
Institute of Clinical Research
Mayfield Heights, Ohio, United States
The Cleveland Pediatric Research Center, LLC
Middleburg Heights, Ohio, United States
Tanner Memorial Clinic
Layton, Utah, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
AL14
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.